India’s Aurobindo Pharma posts third-quarter profit drop on higher expenses
(Reuters) – Indian drugmaker Aurobindo Pharma reported a lower third-quarter profit on Thursday, as a spike in expenses more than offset strong demand for its generic drugs. The company’s consolidated net profit fell 10% to 8.46 billion rupees ($96.6 million) in the quarter ended Dec. 31. Its total revenue from operations climbed 8.5% to 79.79 …
India’s Aurobindo Pharma posts third-quarter profit drop on higher expenses Read More »





